Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Celularity Inc. before investing.

In this article, we go over a few key elements for understanding Celularity Inc.’s stock price such as:

• Celularity Inc.’s current stock price and volume
• Why Celularity Inc.’s stock price changed recently
• Upgrades and downgrades for CELU from analysts
• CELU’s stock price momentum as measured by its relative strength

About Celularity Inc. (CELU)

Before we jump into Celularity Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn’s) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Want to learn more about Celularity Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Celularity Inc..

Celularity Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Celularity Inc.’s stock price was $0.635.

Celularity Inc. is down 6.57% from its previous closing price of $0.680.

During the last market session, Celularity Inc.’s stock traded between $0.601 and $0.720. Currently, there are approximately 28.45 million shares outstanding for Celularity Inc..

Celularity Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Celularity Inc. Stock Price History

Celularity Inc.’s (CELU) price is currently up 6.26% so far this month.

During the month of July, Celularity Inc.’s stock price has reached a high of $0.860 and a low of $0.600.

Over the last year, Celularity Inc. has hit prices as high as $4.310 and as low as $0.560. Year to date, Celularity Inc.’s stock is down 42.77%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Celularity Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Celularity Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Celularity Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Celularity Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Celularity Inc. (CELU) by visiting AAII Stock Evaluator.

Relative Price Strength of Celularity Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Celularity Inc. has a weighted four-quarter relative price strength of -35.90%, which translates to a Momentum Score of 5 and is considered to be Very Weak.

Want to learn more about how Celularity Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Celularity Inc. Stock Price: Bottom Line

As of July 31, 2026, Celularity Inc.’s stock price is $0.635, which is down 6.57% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Celularity Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.